Subvenciones y ayudas para entidades sociales

Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional)

Estados Unidos · US

Quién puede pedirla Private institutions of higher education · City or township governments · Public housing authorities/Indian housing authorities · State governments · Special district governments · Independent school districts · County governments · Native American tribal organizations (other than Federally recognized tribal governments) · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Public and State controlled institutions of higher education · Others (see text field entitled "Additional Information on Eligibility" for clarification) · Native American tribal governments (Federally recognized) · Small businesses · For profit organizations other than small businesses

This Notice of Funding Opportunity (NOFO) for R34 planning grant applications focuses on prevention and intervention strategies for fetal alcohol spectrum disorders (FASD) throughout the lifespan. The intent of this NOFO is to support research that advances (1) prevention approaches to reduce prenatal alcohol exposure and incidence of FASD and (2) interventions for FASD. It is expected that research conducted via this mechanism will consist of studies that are a pre-requisite for preparing and submitting subsequent applications for larger scale FASD prevention or intervention studies. Applicants interested in exploratory phased projects may consider NOFO (TEMP-23833, the R61/R33 option).

Personal Health Informatics for Delivering Actionable Insights to Individuals (R01 Clinical Trial Optional)

Estados Unidos · US

Quién puede pedirla Public and State controlled institutions of higher education · Native American tribal organizations (other than Federally recognized tribal governments) · Native American tribal governments (Federally recognized) · Small businesses · City or township governments · State governments · Private institutions of higher education · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Special district governments · For profit organizations other than small businesses · Public housing authorities/Indian housing authorities · Others (see text field entitled "Additional Information on Eligibility" for clarification) · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · County governments · Independent school districts

The purpose of this Notice of Funding Opportunity (NOFO) is to advance the development of novel informatics and data science approaches that can help individuals understand and improve their health through actionable insights. NLM seeks applications that further the science of personal health informatics by providing meaningful and actionable insights to individuals through innovative personal health data collection, integration, analysis, and personalized risk assessments and interpretation. Applications seeking to advance the understanding of how informatics tools, systems, and platforms can best present the results, interpretation, and limitations of personalized assessments for the benefit of individuals are encouraged. Applications should include end user engaged approaches and real-world evaluation to inform the design of generalizable, reusable, and scalable personal health informatics tools, systems, and platforms for the benefit of individuals in understanding and improving their health.

Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)

Estados Unidos · US

Quién puede pedirla Small businesses · Special district governments · Others (see text field entitled "Additional Information on Eligibility" for clarification) · Public housing authorities/Indian housing authorities · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Public and State controlled institutions of higher education · Independent school districts · Native American tribal organizations (other than Federally recognized tribal governments) · Private institutions of higher education · For profit organizations other than small businesses · State governments · City or township governments · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · County governments · Native American tribal governments (Federally recognized)

The goal of the proposed funding announcement is twofold, to promote preclinical and patient based studies examining the mechanism(s) through which incretin mimetics (including agonists or antagonists of GLP-1, GIP-1, or dual GLP-1/GIP-1 agents) impact cancer risk, and to draw talented scientists who understand the dynamic changes caused by these agents to investigate the mechanisms of how these agents influence cancer risk rather than shorter term outcomes such as weight loss and diabetes. The data thus far suggests that these agents may increase the risk of some, while decreasing the risk of other obesity related cancers.

Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)

Estados Unidos · US

Quién puede pedirla Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · For profit organizations other than small businesses · Small businesses · Special district governments · County governments · City or township governments · State governments · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Private institutions of higher education · Native American tribal governments (Federally recognized) · Independent school districts · Native American tribal organizations (other than Federally recognized tribal governments) · Others (see text field entitled "Additional Information on Eligibility" for clarification) · Public and State controlled institutions of higher education · Public housing authorities/Indian housing authorities

The goal of the proposed funding announcement is twofold, to promote preclinical and patient based studies examining the mechanism(s) through which incretin mimetics (including agonists or antagonists of GLP-1, GIP-1, or dual GLP-1/GIP-1 agents) impact cancer risk, and to draw talented scientists who understand the dynamic changes caused by these agents to investigate the mechanisms of how these agents influence cancer risk rather than shorter term outcomes such as weight loss and diabetes. The data thus far suggests that these agents may increase the risk of some, while decreasing the risk of other obesity related cancers.

Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed)

Estados Unidos · US

Quién puede pedirla Special district governments · Native American tribal governments (Federally recognized) · County governments · Public housing authorities/Indian housing authorities · Small businesses · City or township governments · Public and State controlled institutions of higher education · Others (see text field entitled "Additional Information on Eligibility" for clarification) · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Private institutions of higher education · For profit organizations other than small businesses · Independent school districts · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · Native American tribal organizations (other than Federally recognized tribal governments) · State governments

The goal of this NOFO is to support R21 applications for novel theory and methods development that better delineate how genetic and non-genetic factors contribute to complex trait variation across individuals, families, and populations. Approaches should be interdisciplinary across the natural and social sciences, account for interdependencies across scales of biological, social, and ecological organization, and make extensive use of theory, simulations, and validation using available large-scale datasets

Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)

Estados Unidos · US

Quién puede pedirla For profit organizations other than small businesses · Private institutions of higher education · Native American tribal organizations (other than Federally recognized tribal governments) · Others (see text field entitled "Additional Information on Eligibility" for clarification) · Independent school districts · Public and State controlled institutions of higher education · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · State governments · Small businesses · County governments · Special district governments · Native American tribal governments (Federally recognized) · City or township governments · Public housing authorities/Indian housing authorities

Through this notice of funding opportunity (NOFO), the National Cancer Institute (NCI) invites applications for support of investigator-initiated clinical trials that have the potential to reduce the burden of cancer through improvements in early detection, screening, prevention and interception, healthcare delivery, quality of life, and/or survivorship related to cancer; with such attributes, the proposed studies should also have the potential to improve clinical practice and/or public health. Applications submitted to this NOFO must include studies that meet the National Institutes of Health (NIH) definition of a clinical trial (see NOT-OD-15-015 for details) and provide specific clinical trial information as described in this FOA. This NOFO does not and will not support clinical trials for studies of cancer diagnosis and/or oncologic therapy in patients. The proposed investigator-initiated projects should be related to the programmatic interests of the NCI Division of Cancer Prevention and/or the NCI Division of Cancer Control and Population Sciences.

National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)

Estados Unidos · US

Quién puede pedirla Small businesses · Native American tribal governments (Federally recognized) · City or township governments · State governments · Public and State controlled institutions of higher education · County governments · Others (see text field entitled "Additional Information on Eligibility" for clarification) · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · Native American tribal organizations (other than Federally recognized tribal governments) · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Public housing authorities/Indian housing authorities · Special district governments · Independent school districts · Private institutions of higher education · For profit organizations other than small businesses

Through this Notice of Funding Opportunity, the National Cancer Institute (NCI) seeks research projects that implement early phase (Phase 0, I, and II) investigator-initiated clinical trials focused on cancer-targeted diagnostic and therapeutic interventions of direct relevance to the research mission of DCTD and OHAM. The proposed project must involve at least 1 clinical trial related to the scientific interests of one or more of the following research programs: Cancer Therapy Evaluation Program, Cancer Imaging Program, Cancer Diagnosis Program, Radiation Research Program, Complementary and Alternative Medicine Program and/or the HIV and AIDS Malignancies Research Programs. Applicants may propose to conduct an early phase trial by itself, or in combination with another research aim(s) as appropriate.

Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional)

Estados Unidos · US

Quién puede pedirla Public and State controlled institutions of higher education · For profit organizations other than small businesses · Public housing authorities/Indian housing authorities · Independent school districts · City or township governments · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Special district governments · Native American tribal governments (Federally recognized) · Small businesses · State governments · Native American tribal organizations (other than Federally recognized tribal governments) · Others (see text field entitled "Additional Information on Eligibility" for clarification) · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · County governments · Private institutions of higher education

This Notice of Funding Opportunity (NOFO) aims to support research on interdisciplinary population approaches to increasing awareness of the relationship between alcohol and cancer risk, understanding and changing social norms related to alcohol consumption, developing and/or evaluating alcohol policy approaches, and the development, testing, and implementation of population-level interventions to reduce alcohol-related cancer risk. Applications that address multiple levels of consumption, such as moderate and heavy drinking, are of particular interest, as well as those focusing on alcohol use disorder (AUD) from the perspective of cancer prevention and control.

Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)

Estados Unidos · US

Quién puede pedirla Private institutions of higher education · For profit organizations other than small businesses · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Others (see text field entitled "Additional Information on Eligibility" for clarification) · Small businesses · Native American tribal organizations (other than Federally recognized tribal governments) · City or township governments · Public housing authorities/Indian housing authorities · Special district governments · County governments · Public and State controlled institutions of higher education · Independent school districts · State governments · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · Native American tribal governments (Federally recognized)

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to stimulate translation of scientific discoveries and engineering developments in imaging, data science and/or spectroscopic technologies into methods or tools that address contemporary problems in understanding the fundamental biology, potential risk of development, diagnosis, treatment, and/or disease status for cancer or other disease.

Intervenciones para ampliar la detección del cáncer y los servicios preventivos para AVANZAR la salud en poblaciones que experimentan disparidades de salud (R01, se requiere ensayo clínico)

Estados Unidos · US

Quién puede pedirla Others (see text field entitled "Additional Information on Eligibility" for clarification) · Special district governments · State governments · Native American tribal organizations (other than Federally recognized tribal governments) · Public housing authorities/Indian housing authorities · Public and State controlled institutions of higher education · Private institutions of higher education · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · For profit organizations other than small businesses · Small businesses · County governments · Independent school districts · City or township governments · Native American tribal governments (Federally recognized)

La Oficina de Prevención de Enfermedades (ODP) y los Institutos, Centros y Oficinas (IC) participantes de los Institutos Nacionales de Salud (NIH) emiten este R01 para solicitar solicitudes para abordar las barreras y los facilitadores que impiden el uso o la adopción de la detección del cáncer y los servicios preventivos en poblaciones que experimentan disparidades de salud. Las intervenciones deben incluir detección, servicios preventivos u otros procesos de atención médica, incluido el seguimiento oportuno de hallazgos anormales y la derivación a atención accesible. Se alienta a los proyectos a aprovechar las colaboraciones con socios comunitarios y proveedores de servicios. Las intervenciones deben abordar las barreras y los facilitadores en dos o más de los siguientes niveles: paciente, médico, entorno de atención médica y vecindario/comunidad. Los intereses de investigación específicos de los IC participantes de los NIH se detallan a continuación.

Premio de Mejora de la Investigación Académica (AREA) para Instituciones Enfocadas en Estudiantes Universitarios (R15 Ensayo Clínico Requerido)

Estados Unidos · US

Quién puede pedirla Public and State controlled institutions of higher education · Others (see text field entitled "Additional Information on Eligibility" for clarification) · Private institutions of higher education

El propósito de este Premio de Mejora de la Investigación Académica (AREA) para Instituciones Enfocadas en Estudiantes Universitarios es apoyar subvenciones de investigación a pequeña escala en instituciones que no reciben financiación sustancial del NIH, con énfasis en proporcionar experiencias de investigación biomédica principalmente para estudiantes universitarios y mejorar el entorno de investigación en las instituciones solicitantes. Las instituciones elegibles deben otorgar títulos de licenciatura en ciencias y no haber recibido más de $6 millones de dólares por año de apoyo del NIH (tanto en costos directos como F y A/indirectos) en 4 de los últimos 7 años fiscales. Para las instituciones compuestas por múltiples escuelas y facultades, el límite de financiación de $6 millones se basa en la cantidad de financiación del NIH recibida por todas las escuelas y facultades no profesionales de la salud dentro de la institución en su conjunto. Esta Notificación de Oportunidad de Financiación (NOFO) apoya ensayos clínicos mecanicistas y/o de riesgo mínimo iniciados por investigadores que abordan la misión y los intereses de investigación de los institutos participantes del NIH. Para los fines de esta NOFO, los ensayos clínicos de riesgo mínimo se definen como aquellos que no requieren la supervisión de la FDA, no tienen la intención de establecer formalmente la eficacia y tienen bajos riesgos de causar daño físico o psicológico.

Cancer Research Education Grants Program - Courses for Skills Development (R25 Clinical Trial Not Allowed)

Estados Unidos · US

Quién puede pedirla Special district governments · Public housing authorities/Indian housing authorities · Public and State controlled institutions of higher education · Native American tribal organizations (other than Federally recognized tribal governments) · City or township governments · County governments · State governments · Small businesses · Independent school districts · Others (see text field entitled "Additional Information on Eligibility" for clarification) · Native American tribal governments (Federally recognized) · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Private institutions of higher education · For profit organizations other than small businesses

The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this NCI R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nations biomedical, behavioral and clinical research needs. To accomplish the stated over-arching goal, this Notice of Funding Opportunity (NOFO) will support creative educational activities with a primary focus on Courses for Skills Development. Applications are encouraged that propose innovative, state-of-the-art programs that address the cause, diagnosis, prevention, or treatment of cancer, rehabilitation from cancer, or the continuing care of cancer patients and the families of cancer patients.

Cancer Research Education Grants Program - Research Experiences (R25 Clinical Trial Not Allowed)

Estados Unidos · US

Quién puede pedirla Special district governments · For profit organizations other than small businesses · State governments · Others (see text field entitled "Additional Information on Eligibility" for clarification) · Native American tribal governments (Federally recognized) · Native American tribal organizations (other than Federally recognized tribal governments) · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · County governments · Independent school districts · City or township governments · Private institutions of higher education · Public housing authorities/Indian housing authorities · Small businesses · Public and State controlled institutions of higher education · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education

The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this NCI R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nations biomedical, behavioral and clinical research needs. To accomplish the stated over-arching goal, this Notice of Funding Opportunity (NOFO) will support creative educational activities with a primary focus on Research Experiences. Applications are encouraged that propose innovative, state-of-the-art programs that address the cause, diagnosis, prevention, or treatment of cancer, rehabilitation from cancer, or the continuing care of cancer patients and the families of cancer patients.

Cancer Research Education Grants Program - Curriculum or Methods Development (R25 Clinical Trial Not Allowed)

Estados Unidos · US

Quién puede pedirla State governments · For profit organizations other than small businesses · Special district governments · Native American tribal organizations (other than Federally recognized tribal governments) · Small businesses · Public and State controlled institutions of higher education · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Others (see text field entitled "Additional Information on Eligibility" for clarification) · Private institutions of higher education · County governments · Independent school districts · City or township governments · Public housing authorities/Indian housing authorities · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · Native American tribal governments (Federally recognized)

The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this NCI R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nations biomedical, behavioral and clinical research needs. To accomplish the stated over-arching goal, this Notice of Funding Opportunity (NOFO) will support creative educational activities with a primary focus on Curriculum or Methods Development. Applications are encouraged that propose innovative, state-of-the-art programs that address the cause, diagnosis, prevention, or treatment of cancer, rehabilitation from cancer, or the continuing care of cancer patients and the families of cancer patients.

Convocatoria Premios Castellitx 2027

LOCAL - ALGAIDA - AYUNTAMIENTO DE ALGAIDA ·

Cultura

Ejecución: 1/10/2026 – —

Discovery of the Genetic Basis of Childhood Cancers and of Congenital Anomalies: Gabriella Miller Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed)

Estados Unidos · US

Quién puede pedirla State governments · City or township governments · Others (see text field entitled "Additional Information on Eligibility" for clarification) · Public and State controlled institutions of higher education · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · Native American tribal governments (Federally recognized) · Independent school districts · Native American tribal organizations (other than Federally recognized tribal governments) · Special district governments · For profit organizations other than small businesses · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Small businesses · County governments · Private institutions of higher education · Public housing authorities/Indian housing authorities

As part of the Gabriella Miller Kids First Pediatric Research Program (Kids First Program), the NIH invites applications to submit samples from pediatric cohorts for whole genome sequencing at a Kids First Program supported genomic data generating centers. Applicants are encouraged to propose sequencing of existing pediatric cancer or congenital anomaly cohorts to elucidate the genetic contribution (somatic and/or germline) to childhood cancers, to investigate the genetic etiology of congenital anomalies, to study the molecular basis of the associations between congenital anomalies and increased cancer risk, or to expand the range of pediatric disorders included within the Kids First Data Resource. The program will accept applications that propose whole genome, exome, and transcriptome sequencing, as well as clinical-grade sequencing, long-read sequencing, proteomics, and epigenomic assays of tumor or affected tissue, when justified. Applicants are encouraged to propose cohorts to increase representation of existing Kids First Program projects. These data, and associated clinical and phenotypic data, will become part of the Kids First Data Resource Center for sharing with the research community.

Title X Family Planning Services Grants

Estados Unidos · US

Quién puede pedirla County governments · City or township governments · Public and State controlled institutions of higher education · Others (see text field entitled "Additional Information on Eligibility" for clarification) · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · Native American tribal organizations (other than Federally recognized tribal governments) · Private institutions of higher education · Native American tribal governments (Federally recognized) · State governments · Independent school districts · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Special district governments · Public housing authorities/Indian housing authorities

The Office of Population Affairs (OPA) announces the anticipated availability of funds for Fiscal Year (FY) 2027 grants under the authority of Title X of the Public Health Service Act, Section 1001 (42 U.S.C. §300).This notice solicits applications for projects to provide Title X services throughout the 50 United States, District of Columbia, Guam, the Commonwealth of Puerto Rico, the Northern Mariana Islands, the U.S. Virgin Islands, American Samoa, the U.S. Outlaying Islands (Midway, Wake, et al.), the Republic of the Marshall Islands, the Federated State of Micronesia, and the Republic of Palau (hereafter, States). OPA intends to make available approximately up to $257 million for up to 90 grant awards for a period of up to five (5) years. The actual amount available will not be determined until enactment of the FY 2027 federal budget.OPA"s Title X Family Planning Program funds "voluntary family planning projects [that] offer a broad range of acceptable and effective family planning methods and services (including natural family planning methods, infertility services, and services for adolescents)." (Title X of the Public Health Service Act, 42 U.S.C. 300 et seq., available at https://opa.hhs.gov/sites/default/files/2020-07/title-x-statute-attachment-a_0.pdf). The Title X Program is implemented through competitively awarded grants to a diverse network of public and private nonprofit entities. The program helps millions of low-income and uninsured Americans develop health literacy and access family planning and related health services, empowering individuals and families to make informed decisions and navigate chronic health conditions and pregnancy with confidence. By offering counseling and education to improve individuals" optimal health outcomes, Title X promotes the level of health literacy necessary to support informed consent across the reproductive lifespan. For example, endometriosis often goes undiagnosed for years because symptoms such as severe menstrual pain or irregular bleeding are frequently normalized or minimized. Body literacy counseling helps patients recognize that these experiences are not "normal" features of womanhood, but potential indicators of an underlying condition, prompting earlier discussion with providers, timely diagnosis, appropriate treatment, and improved long-term reproductive and overall health outcomes.Likewise, foundational knowledge of reproductive physiology enables patients and couples to recognize early signs of dysfunction, seek timely evaluation, and participate meaningfully in care decisions. Persistent gaps in reproductive knowledge highlight the need for such education. For example, a survey conducted for OPA in 2020 found that only 50% of women and 38% of men know that a woman"s ovaries do not keep producing new eggs until menopause (https://opa.hhs.gov/sites/default/files/2021-01/fertility-knowledge-survey-findings-exec-summary-2020.pdf). By supporting body literacy education alongside evidence-based evaluation and treatment of chronic disease, Title X services can help patients move beyond symptom-focused care toward informed, preventive, and restorative approaches to reproductive health.These efforts align with HHS"s focus on addressing the root causes of chronic illnesses by targeting conditions that affect reproductive health and fertility. By promoting strategies that support education and counseling on reproductive health goals, reduce chronic disease, and assist individuals seeking to achieve healthy pregnancies, the Title X Program strengthens American families, individuals, and communities.This notice solicits applications from public and private nonprofit entities to establish and operate voluntary Title X projects. These projects include a broad range of effective and acceptable services, including pregnancy testing and counseling, basic infertility services, sexually transmitted infection (STI) services (such as HIV prevention education, counseling, testing, and referral), health literacy, reproductive goals counseling to increase optimal health outcomes, and other preconception health services. Title X services also help address and provide referrals for health conditions that affect fertility, including endometriosis, polycystic ovary syndrome (PCOS), and uterine fibroids in women, as well as low sperm count, low sperm motility, low testosterone, and erectile dysfunction in men. OPA seeks a broad competition for Title X grant awards and are interested in innovative strategies to address chronic disease; reduce overmedicalization by strengthening approaches focused on underlying behavioral and lifestyle factors of health and evidence-based practices such as fertility-awareness based methods; promote health and body literacy; advance reproductive goals counseling for all clients; and support family formation.All activities funded under this announcement must be in compliance with the requirements of the Title X statute, legislative mandates, and regulations. Copies of the Title X statute, regulations, and legislative mandates may be downloaded from the OPA website at https://opa.hhs.gov/grant-programs/title- x-service-grants/title-x-statutes-regulations-and-legislative-mandates.

Oceanographic Facilities and Equipment Support

Estados Unidos · US

Quién puede pedirla Others (see text field entitled "Additional Information on Eligibility" for clarification)

Oceanographic facilities and equipment are supported by the Integrative Programs Section (IPS) of the Division of Ocean Sciences (OCE), Directorate for Geosciences (GEO). These awards are made for the procurement, conversion and/or upgrade, enhancement, or annual operation of platforms in the ocean, coastal and near-shore waters, and Great Lakes. Awards are generally directed specifically to support facilities that lend themselves to shared use within the broad range of Federally supported research and education programs.Most of these platforms and facilities also receive partial support from other federal agencies, state and local governments, and private sources on a proportional basis usually through a daily rate mechanism. The primary objective of these awards is to ensure the availability of appropriate oceanographic facilities for Federally funded investigators and educators. Individual project-based facilities and instrumentation, limited to one, or a small group of, investigator(s), should be supported through appropriate research programs as opposed to through the IPS programs listed herein. The individual programs covered within this solicitation include: 1. Oceanographic Technical Services (Tech Services) 2. Oceanographic Instrumentation (OI) 3. Shipboard Scientific Support Equipment (SSSE) Oceanographic Technical Service (Tech Services): The Tech Services Program provides support of institutional technical services to enhance the scientific productivity of research programs, aboard research vessels and in shore-based, shared-use facilities. Research vessel technical services include quality assurance, scheduling of technical support, logistical assistance, and at-sea supervision of the instrumentation and shared-use equipment available to sea-going researchers. This program also provides baseline operational support for the University-National Oceanographic Laboratory System (UNOLS) equipment pools (wire, vans and winches). Support of research vessel technical services and UNOLS equipment pools includes salaries and related expenses, maintenance and calibration of sensors and instrumentation, and associated travel. Oceanographic technical services support requests must be directly attributable to NSF-sponsored science. With the exception of the wire pool, requests for new or replacement capital equipment must be made through the SSSE or OI programs. Oceanographic Instrumentation (OI): The OI Program provides support to enhance the scientific capabilities and productivity of seagoing research projects that utilize research vessels as well as shore-based, shared-use facilities. Proposals may include shared-use instrumentation for the collection, processing, and analysis of oceanographic data. Typical instrumentation includes sensors, acoustic systems, data loggers, water sampling rosettes, biological net systems, coring equipment and auto-analyzers. Proposals must be for instrumentation that will support multiple research projects.OI proposals are generally submitted by the institution's Tech Services manager whose operational funding is provided through the OCE Technical Services Program. Shipboard Scientific Support Equipment (SSSE): The SSSE Program provides support to improve safety and enhance scientific capabilities and productivity of seagoing research programs that utilize research vessels as well as shore-based, shared-use facilities.. Proposals may include new permanent or portable equipment required to outfit a vessel to conduct oceanographic research as well as overhaul of equipment previously funded under this program, including science handling systems (winches, frames, cranes, etc.), navigation and communication equipment, and safety and regulatory-related items. Requests for purchase of new winch pool or van pool capital equipment must be submitted to this program. SSSE proposals are generally submitted by the institution's Marine Superintendent whose operational funding is provided through the Ship Operations Program in OCE.

Grand Challenge on Quantum Sensors for Inertial Navigation

Unión Europea · EU

Grand Challenge on Quantum Sensors for Inertial Navigation

Ejecución: 2/6/2026 – —

Convocatoria 2026 de concesión de subvenciones para la rehabilitación de fachadas de Constantí "Constantí Ponte Bonito".

LOCAL - CONSTANTÍ - AYUNTAMIENTO DE CONSTANTÍ ·

Acceso a la vivienda y fomento de la edificación

Convocatoria 2026 de Subvenciones a Asociaciones de Vecinos.

LOCAL - TOMELLOSO - AYUNTAMIENTO DE TOMELLOSO ·

Cultura

Ejecución: 19/3/2026 – —

Convocatoria 2026 de Subvenciones a Asociaciones Culturales.

LOCAL - TOMELLOSO - AYUNTAMIENTO DE TOMELLOSO ·

Cultura

Ejecución: 20/3/2026 – —

Investigación Antártica que No Requiere Apoyo de Campo del Programa Antártico de EE. UU. (USAP)

Estados Unidos · US

Quién puede pedirla Others (see text field entitled "Additional Information on Eligibility" for clarification)

A través de esta solicitud, la Sección de Ciencias Antárticas (ANT) de la Oficina de Programas Polares (OPP) financia investigación de vanguardia que: Mejora la comprensión de las interacciones entre la región antártica y los sistemas globales. Mejora la comprensión de los vínculos dinámicos entre los procesos que operan en la Antártida y el Océano Austral y los vínculos con los sistemas terrestres globales, lo que ayuda a informar la toma de decisiones con respecto al cambio ambiental. Avanza la comprensión fundamental de los sistemas terrestres y los procesos biológicos, geoquímicos y físicos en la Antártida y el Océano Austral como impulsores y respondedores a los cambios a escala global. Expande el conocimiento fundamental de los sistemas, la biota y los procesos antárticos. Utiliza las características únicas de la región antártica como plataforma de observación científica. Desarrolla capacidad y mejora la fuerza laboral de EE. UU. para la ciencia relacionada con los polos. ANT fomenta y apoya la investigación que combina perspectivas y enfoques disciplinarios de otros campos, la investigación que utiliza datos y muestras existentes, y otras investigaciones que no requieren una presencia física en la Antártida. Esto puede incluir proyectos realizados en ubicaciones fuera de la Antártida que sirven como análogos de sitios o sistemas antárticos. <a id="_anchor_3" name="_msoanchor_3" href="https://www.nsf.gov/cgi-bin/good-bye?https://nsf-my.sharepoint.com/personal/0812601541_nsf_gov/Documents/OPP/ANT/ANT%20Proposals%20Data%20Solicitations%20…

HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)

Estados Unidos · US

Quién puede pedirla Special district governments · Public and State controlled institutions of higher education · For profit organizations other than small businesses · State governments · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · Small businesses · County governments · Others (see text field entitled "Additional Information on Eligibility" for clarification) · Private institutions of higher education · Native American tribal governments (Federally recognized) · Independent school districts · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Public housing authorities/Indian housing authorities · Native American tribal organizations (other than Federally recognized tribal governments) · City or township governments

This funding opportunity is part of a suite of NOFOs within the NIH HEAL Initiative to support the development of safe, effective, and non-addictive therapeutics to treat pain. The goal is to encourage initial translational efforts that will support a drug discovery program and advance projects to the point where they meet the entry criteria for the Pain Therapeutics Development Program. The scope will therefore be focused on development of assays to support a distinct testing funnel, screening efforts to identify hits, and initial characterization of hits and potential therapeutic agents (including small molecules, biologics, and natural products).